BIM
WVE icon

BlackRock Investment Management’s Wave Life Sciences WVE Stock Holding History

BlackRock Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$735K Buy
28,121
+162
+0.6% +$5.27K ﹤0.01% 2873
2016
Q3 		$908K Sell
27,959
-40
-0.1% -$945 ﹤0.01% 2742
2016
Q2 		$579K Buy
+27,999
New +$436K ﹤0.01% 2986

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management's WVE Position: Q4 2016 in Review

BlackRock Investment Management increased its Wave Life Sciences (WVE) stake by 0.58% in Q4 2016, buying an estimated $5.27K and bringing the position to 28,121 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

BlackRock Investment Management first reported a position in WVE in Q2 2016 and has held it in 3 quarters since. The position peaked at $908K in Q3 2016. 51 funds tracked by Wall St. Rank hold WVE as of Q4 2016.

  • BlackRock Investment Management held 28,121 shares of Wave Life Sciences worth $735K as of Q4 2016.
  • BlackRock Investment Management bought 162 Wave Life Sciences shares in Q4 2016, an estimated $5.27K.
  • Wave Life Sciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2873 holding.
  • BlackRock Investment Management first reported a position in Wave Life Sciences in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Investment Management's Wave Life Sciences position peaked at $908K in Q3 2016.
  • 51 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.